Home / Health / Veteran's Life Saved by Revolutionary Blood Cancer Treatment
Veteran's Life Saved by Revolutionary Blood Cancer Treatment
20 Oct
Summary
- New STARGLO treatment offers hope for aggressive blood cancer patients.
- RAF engineer recovered after conventional chemotherapy failed.
- Treatment targets lymphoma in two ways, allowing immediate start.
A veteran Royal Air Force engineer from Derbyshire has expressed profound gratitude for the STARGLO treatment, which has been instrumental in his recovery from an aggressive blood cancer. This innovative therapy, now available through the NHS, is one of the first treatments for diffuse large B-cell lymphoma offered to patients in England.
Tim Swinburn, who previously served 30 years repairing fighter jets, was diagnosed with non-Hodgkin lymphoma after experiencing difficulties swallowing. Despite initial chemotherapy proving ineffective, Swinburn was referred to Professor Chris Fox at Nottingham University Hospitals, where he received the STARGLO treatment. This bi-specific antibody therapy targets lymphoma cells in two distinct ways at once, offering a faster alternative to other treatments like CAR-T therapy.
Following successful trials and approval by NICE, STARGLO is now accessible in NHS hospitals. Professor Fox highlighted the significance of Swinburn's positive outcome, emphasizing the ongoing need for new therapies for lymphoma patients. Swinburn's successful recovery has enabled him to resume his career as an engineering auditor and enjoy his passion for motorbiking, feeling optimistic about the future.
